Search research articles
Contact Us
Filters
Showing results (1181-1190 of 1,198) with videos related to
Page
of 120
Sort By:
Med (New York, N.Y.)
|
April 11, 2022
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons
Chrispin Chaguza, Andreas Coppi, Rebecca Earnest, et al.
Npj Viruses
|
April 28, 2025
Survey of white-footed mice (Peromyscus leucopus) in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses
Rebecca Earnest, Anne M Hahn, Nicole M Feriancek, et al.
Frontiers in Oncology
|
November 19, 2015
Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs
Surbhi Grover, Mmakgomo Raesima, Memory Bvochora-Nsingo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
H Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2016
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
Noah M Hahn, Trinity J Bivalacqua, Ashley E Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
Breast Cancer Research and Treatment
|
May 8, 2020
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015
Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<sup></sup>
Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
Seth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer
Elaine Chang, Noah M Hahn, Seth P Lerner, et al.
Page
of 120
Search research articles
Search
Showing results (1181-1190 of 1,198) with videos related to
Sort By:
Page
of 120
Med (New York, N.Y.)
|
April 11, 2022
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons
Chrispin Chaguza, Andreas Coppi, Rebecca Earnest, et al.
Npj Viruses
|
April 28, 2025
Survey of white-footed mice (Peromyscus leucopus) in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses
Rebecca Earnest, Anne M Hahn, Nicole M Feriancek, et al.
Frontiers in Oncology
|
November 19, 2015
Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs
Surbhi Grover, Mmakgomo Raesima, Memory Bvochora-Nsingo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
H Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2016
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
Noah M Hahn, Trinity J Bivalacqua, Ashley E Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
Breast Cancer Research and Treatment
|
May 8, 2020
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015
Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<sup></sup>
Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
Seth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer
Elaine Chang, Noah M Hahn, Seth P Lerner, et al.
Page
of 120